Already have an account?


Login with an existing Projects In Knowledge account Log in with your MPT account
New to Projects In Knowledge?


Register today to customize your experience.
Log In
Don't have an account yet? Click here to register



Register for Free
Already have an account? Click here to log in



Enter your current email address.  Your email address will be your user name, and where you will receive confirmation of this registration.



Forgot Password

Please Enter your email address.




  Terms & Conditions                                                                                                                                     

Privacy Policy

Projects In Knowledge is committed to protecting the privacy and confidentiality of visitors to our Web site. While Projects In Knowledge does not require that you provide us with personally identifiable information in order to visit our Web site, please note that in order to participate in the continuing medical education activities that we provide, it will be necessary for you to register with us and provide this information.

About this Privacy Policy
www.projectsinknowledge.com is our Web site for physicians and allied health care professionals, although it is open to non-professionals as well. The purpose of projectsinknowledge.com is to provide continuing medical education for healthcare professionals, and is intended for use only by a licensed healthcare professional.

Projects In Knowledge is the name we use to refer to our entire company, even though our formal corporate name is Projects In Knowledge, Inc. When we refer to ourselves as "we" or "Projects In Knowledge," we mean our company, Projects In Knowledge, Inc., including any subsidiary that we control (for example, a subsidiary that we own). We may share information among our subsidiaries that we own or control, but it is always protected under the terms of this privacy policy.

This privacy policy applies only to the Projects In Knowledge Web site. You should read the privacy policy at each Web site that you visit after you leave our site. We are not responsible for how other Web sites treat your privacy, once you leave the Projects In Knowledge site.

Privacy Policy Changes
If we change our privacy policy, we will post those changes on this page. Users should check this policy to keep abreast of any changes.

Information We Collect
In this section of our privacy policy, we discuss the different types of information we may collect about you, and the ways in which we collect them.

Information We Collect from Unregistered Visitors
Visitors to our Web site can access the Web site's home page and browse the site without disclosing any personally identifiable information. We do track information provided to us by your browser, including the Web site you came from (known as the "referring URL"), the type of browser you use, the time and date of access, and other information that does not personally identify you.

Information We Collect When You Register
Customers registering on our Web site for continuing medical education activities we provide are asked to provide us with identifying information, such as name, contact information, and other identifying information. On our registration screens, we clearly label which information is required for registration, and which information is optional and may be given at your discretion.

On our registration screens you will also find a “Burning Question” field. Submission of a “Burning Question” is completely voluntary. By submitting a “Burning Question,” you grant Projects In Knowledge the right to share it with faculty to consider as they prepare their continuing medical education presentations.

Listserves
When you are using a listserve—or member-only discussion board— on our Web site, you are posting a message and your user name, which is available for all registered members to see. You should not post any information to our listserves you want to keep private. It is a condition of our Web site that when participating in a listserve, you do not:

  • Restrict or inhibit any other user from using the listserve
  • Post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including, without limitation, any transmission constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or foreign law
  • Post or transmit any information, software or other material which violates or infringes upon the rights of others, including material which constitutes an invasion of privacy or infringement of publicity rights or which is protected by copyright, trademark or other proprietary right, or derivative works thereof, without first obtaining permission from the owner or right holder
  • Post or transmit any information, software or other material which contains a virus or other harmful component
  • Post, or transmit, or in any way exploit any information, software or other material for commercial purposes which contains advertising, promotions or marketing

By sending a message through the listserve, you grant Projects In Knowledge the non-exclusive right and license to display, copy, publish, distribute, transmit, print, and use such information. Projects In Knowledge reserves the right to terminate your access to, and use of, the listserve if you do not abide by these conditions.

Use of Cookies
Cookies are a technology used by the Projects In Knowledge Web site to identify a user as the user moves through the Web site. Your browser allows us to place some information on your computer's hard drive that identifies the computer you are using. We use cookies to track your usage throughout our Web site.

Your Web browser can be set to allow you to control whether you will accept cookies, reject cookies, or to notify you each time a cookie is sent to you. If your browser is set to reject cookies, Web sites that are cookie-enabled will not recognize you when you return to the Web site, and some Web site functionality may be lost. The Help section of your browser will tell you how to prevent your browser from accepting cookies.

Although cookies do not normally contain personally identifiable information, if you are a registered user we may associate your registration information with cookies our Web site places on your computer's hard drive. Associating a cookie with your registration data allows us to offer increased personalization and functionality. For example, you can elect to have our Web site "remember" you and bypass the registration process each time you register for one of our educational activities. Without cookies, this functionality would not be possible. Projects In Knowledge does not currently employ cookies for this use, but is considering it to make our registration processes more efficient for you.

Children's Privacy
Projects In Knowledge's Web site is designed and intended for use by adults, and is not intended for, nor designed to be used by children under the age of 18, or any other unlicensed, untrained individuals. We do not collect personally identifiable information from any person we know is a child under the age of 18.

Uses We Make of Information
In this section of our privacy policy, we identify the ways we may use information about you that we have collected.

Aggregate Data
We create aggregate data about visitors to our Web site for activity development and improvement. We also use it for market analysis. We may provide information from our Web site in aggregate form, with identifying information removed, to third parties. For example, we may tell a third party what percentage of our registered users reside in a particular geographical area. When aggregated information is provided, we pool it from many individual records and strip it of any data that could be used to identify an individual before it is used. Any third party that receives aggregated data must agree not to attempt to re-identify the people it belongs to. Projects In Knowledge does not sell any user data to any third party for commercial purposes.

Third Parties
In addition to aggregate information (discussed previously), we may share some kinds of information with third parties as described below.

  • Business Transfers: If we transfer a business unit (such as a subsidiary) or an asset (such as a Web site) to another company, we will require them to honor the applicable terms of this privacy policy.

Protection of Information
In this section of our privacy policy, we discuss the security measures we take to protect information that we have collected about you.

General Policies
We have implemented technology and security policies, rules and other measures to protect the personal data that we have under our control from unauthorized access, improper use, alteration, unlawful or accidental destruction, and accidental loss. We also protect your information by requiring that all our employees and others who have access to or are associated with the processing of your data respect your confidentiality. In addition, we have appropriate security measures in place in our physical facilities to protect against the loss or misuse of information at our site that we have collected from you.

Projects In Knowledge Employees
Projects In Knowledge employees are required to keep customer information private, as a condition of their employment with the company. Only selected, authorized Projects In Knowledge employees are permitted to access your registration information.
Employees are required to sign a confidentiality agreement. All employees and contractors must abide by our privacy policy, and those who violate that policy are subject to disciplinary action, up to and including termination of their employment and legal action.

Privacy Questions or Concerns about Our Web Site
For privacy questions or concerns about the Projects In Knowledge Web site, please contact privacy@projectsinknowledge.com.

Revision date: This policy was last updated on September 30, 2003.



New and Noteworthy


  • Lung Cancer — Targeted Therapy for Advanced Squamous NSCLC – @Point of Care Chapter
  • Squamous cell lung cancer is the second most common histologic subtype of non-small cell lung cancer (NSCLC), accounting for up to 20% to 30% of cases. Two targeted therapies are currently approved for treatment of patients with advanced squamous NSCLC: necitumumab and afatinib. In this activity, Dr. Thomas ... more >>
    T. Stinchcombe, MD
  • Lung Cancer — Treatment of Advanced NSCLC by Targeting the VEGF Pathway – @Point of Care Chapter
  • Vascular endothelial growth factor (VEGF) plays a central role in the regulation of angiogenesis by promoting endothelial cell migration and proliferation. Current therapies that target the VEGF pathway in advanced non-small cell lung cancer include bevacizumab and ramucirumab. In this activity, Dr. Thomas ... more >>
    T. Stinchcombe, MD
  • Leukemia — Master Class: Chronic Lymphocytic Leukemia – Curriculum
  • Master Class: Chronic Lymphocytic Leukemia (CLL) is designed to highlight relevant, practical advances in the treatment of CLL using a modular structure to provide an in-depth review of best practices with multiple complementary activities, including video webcasts with expert clinical specialists, case ... more >>
    B. Cheson, MD, FACP, FAAAS
  • Leukemia — Undetectable Minimal Residual Disease With Novel Agents: Can It Be Achieved? – Webcast
  • Minimal residual disease (MRD) has been used a guide for treatment decisions in chemoimmunotherapy-treated patients with chronic lymphocytic leukemia (CLL) due to its value in predicting progression-free survival and overall survival. Its role in guiding treatment decisions for patients treated with targeted ... more >>
    S. O'Brien, MD, MA, BA
    W. Wierda, MD, PhD
  • Leukemia — Targeting BCL-2 and CD20 for the Treatment of Relapsed/Refractory CLL – Article Review
  • Join Dr. Susan O’Brien for this analysis of the efficacy and safety of combination therapy that targets BCL-2 and CD20 for the treatment of relapsed and refractory chronic lymphocytic leukemia. The trial compares the outcomes of treatment with venetoclax plus rituximab vs that with bendamustine plus rituximab ... more >>
    S. O'Brien, MD, MA, BA
  • Stroke Prevention — Management of a Patient With Atrial Fibrillation Following Percutaneous Coronary Intervention – @Point of Care Chapter
  • This case demonstrates the real-life clinical scenario of a patient with atrial fibrillation who develops myocardial ischemia and undergoes a percutaneous coronary intervention (PCI). It highlights important considerations in the management of such cases, including consideration of dual or triple ... more >>
    P. Dorian, MD
  • Stroke Prevention — Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation: Current and Emerging Options – @Point of Care Chapter
  • Oral anticoagulant therapy is the only highly effective therapy to reduce the increased risk of stroke faced by patients with atrial fibrillation (AF), but many patients who could benefit are not treated. Anticoagulants introduced in recent years have been shown in definitive large randomized clinical trials ... more >>
    S. Connolly, MD, FRCPC
  • Heart Failure — Patient Post-Myocardial Infarction With Class III Heart Failure and Complaints of Dyspnea – @Point of Care Chapter
  • Patients with heart failure with a reduced ejection fraction should be managed using optimized guideline- and evidence-based medications. This case illustrates the real-life clinical scenario of a patient who develops heart failure after an acute myocardial infarction, demonstrating the optimization of his ... more >>
    B. Bozkurt, MD, PhD
  • Stroke Prevention — New and Emerging Reversal Agents in the Era of Non-Vitamin K Antagonist Oral Anticoagulants – @Point of Care Chapter
  • From the initial approval of the first non-vitamin K oral anticoagulant in 2010 to the subsequent approval of four additional agents, along with expansion of their approved indications for use, physicians were provided with additional efficacious and safe options for patients who require anticoagulation for ... more >>
    A. Spyropoulos, MD
  • Multiple Sclerosis — Practical Analysis of: Patient-Reported Outcomes in Relapsing Forms of MS: Real-World, Global Treatment Experience With Teriflunomide From the Teri-PRO Study – Practical Analysis
  • Phase III trials have demonstrated the efficacy and safety of teriflunomide in relapsing multiple sclerosis patients. Real-world studies, which employ broader inclusion criteria, and use of patient-reported outcomes can provide further understanding of treatment outcomes. Join Dr. John Rinker as he discusses ... more >>
    J. Rinker, MD
  • Master Class: Chronic Lymphocytic Leukemia
  • Master Class: Chronic Lymphocytic Leukemia (CLL) is designed to highlight relevant, practical advances in the treatment of CLL using a modular structure to provide an in-depth review of best practices with multiple complementary activities, including video webcasts with expert clinical specialists, case ... more >>
    B. Cheson, MD, FACP, FAAAS
  • State of the Science: Multiple Sclerosis Innovations
  • State of the Science: Multiple Sclerosis Innovations provides comprehensive and up-to-date best practices in multiple sclerosis management. This includes innovative webcasts derived from major scientific conferences synthesized for the practicing clinician, interactive practice-based cases, and articles from ... more >>
    A. Cross, MD
  • The Art & Science of Heart Failure Management
  • The Art & Science of Heart Failure Management is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in heart failure ... more >>
    J. Udelson, MD
  • Pulmonology Mastery in COPD
  • Pulmonology Mastery in COPD is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in COPD. The curriculum includes ... more >>
    B. Make, MD
  • Mastery of Medicine in Diabetes Management
  • Mastery of Medicine in Diabetes Management is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in diabetes ... more >>
    V. Fonseca, MD, FRCP
  • Clinical Context: Stroke Prevention in Atrial Fibrilation
  • Clinical Context: Stroke Prevention in
    Atrial Fibrillation
    is designed to provide up-to-date information on patient identification, risk factors, and current and emerging treatments and best practices in the management of atrial fibrillation.

    The curriculum includes:
    • 6 case studies
    • MedPage Today meeting
    ...
    more >>
    C. Yancy, MD, MSc
  • Hematology Mastery in Multiple Myeloma
  • Hematology Mastery in Multiple Myeloma is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in multiple myeloma. ... more >>
    N. Raje, MD
  • Rheumatology Mastery in Rheumatoid Arthritis
  • Rheumatology Mastery in Rheumatoid Arthritis is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in rheumatoid ... more >>
    M. Husni, MD, MPH
  • Neurology Mastery in Multiple Sclerosis
  • Neurology Mastery in Multiple Sclerosis is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in multiple sclerosis. ... more >>
    J. Bowen, MD
  • Rheumatology Mastery In Ankylosing Spondylitis
  • Rheumatology Mastery in Ankylosing Spondylitis is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in ankylosing ... more >>
    J. Reveille, MD
  • Alzheimer's Disease @Point of Care
  • This @Point of Care is a comprehensive, continually updated resource developed to enhance compliance to established clinical guidelines to improve screening and timely diagnosis of Alzheimer’s disease (AD) and to support current best practices of managing the symptoms of AD.
    R. Turner, MD, PhD
  • Immuno-Oncology @Point of Care: A Focus on Head and Neck Cancer
  • Primary and adjunctive treatment approaches for patients with head and neck squamous cell carcinoma are complex to navigate, requiring assessment of patient-specific risk factors, knowledge of treatment recommendations, and input from a multispecialty team. Furthermore, these patients typically have poor ... more >>
    R. Ferris, MD, PhD
  • Atopic Dermatitis @Point of Care
  • Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, and recent advances in the understanding of the immune and inflammatory processes involved in AD pathogenesis have led to the development and approval of novel therapies for the treatment of this disease. With ... more >>
    L. Eichenfield, M.D.
  • Hypercholesterolemia @Point of Care
  • The Hypercholesterolemia @Point of Care platform provides comprehensive and current information organized into a progressive series of activities and patient cases covering guideline-recommended diagnostic and treatment strategies with up-to-date clinical trial data and insights from top specialists. ... more >>
    M. Miller, MD
  • Rheumatologic Diseases @Point of Care: Ankylosing Spondylitis
  • Axial spondyloarthritis (axSpA) is a chronic rheumatic disorder, comprised of a disease spectrum that ranges from nonradiographic disease to radiographic axSpA, also known as ankylosing spondylitis (AS). As early treatment can reduce disease progression and burden, it is essential that patients be accurately ... more >>
    V. Strand, MD, MACR, FACP
  • Chronic Obstructive Pulmonary Disease @Point of Care
  • Chronic obstructive pulmonary disease (COPD) is highly prevalent in the United States. About 13 million people have a diagnosis of COPD, yet the disease remains underdiagnosed, with an estimated 21 million individuals affected. Cigarette smoking is the primary cause and, while smoking rates have dropped, they ... more >>
    B. Make, MD
  • Heart Failure @Point of Care
  • Heart failure is a significant health burden and, with increasing comorbidities and the aging of the population, this burden is likely to worsen especially in certain populations. Guideline-directed medical therapies have been shown to reduce morbidity and mortality in patients with heart failure, but are ... more >>
    G. Fonarow, MD
  • Hepatocellular Carcinoma @Point of Care
  • This @Point of Care provides a comprehensive, continually updated resource to the clinical care team with relevant and current evidence-based medicine and clinical trial data for approved and emerging therapies to help tailor treatment based on patient characteristics in order to improve the management of ... more >>
    G. Abou-Alfa, MD, MBA
  • Rheumatologic Diseases @Point of Care: Juvenile Idiopathic Arthritis
  • The care and treatment of patients with juvenile idiopathic arthritis (JIA), the most common inflammatory arthritis of childhood, is a rapidly evolving field as the result of recent advances in technology and immunologic treatment. The Juvenile Idiopathic Arthritis @Point of Care platform provides a ... more >>
    P. Weiss, MD, MSCE
  • Multiple Sclerosis — Innovations in Managing Immune Dysfunction in Patients with Multiple Sclerosis - ACTRIMS 2018 Webcast – Webcast
  • Multiple sclerosis (MS) is a chronic immune-mediated inflammatory and neurodegenerative disorder. Advances in our understanding of MS immunopathology have led to the identification of new therapeutic targets and the development of new therapies, with 16 disease-modifying therapies currently available and ... more >>
    T. Leist, MD, PhD
  • Uterine Fibroids — Strategies for Relief: New Approaches to Uterine Fibroids Clinical Highlights from Live Meeting – October 2017
  • Significant progress has recently been made in the management of uterine fibroids, including the development of minimally invasive procedures, fertility-sparing techniques, and pharmacologic options that hold substantial promise to improve morbidity, symptom severity, and quality of life for women with ... more >>
    A. Al-Hendy, MD, PhD
    W. Catherino, MD, PhD
  • Cardiovascular/Diabetes — Cardiovascular Challenges in Diabetes – Video Presentation
  • Although the association between the incidence of diabetes and that of heart failure is well known, the advent of new diabetic therapies now presents an opportunity to modify this interaction, thereby potentially improving outcomes. Join Drs. James Januzzi, Javed Butler, Christopher P. Cannon, Mikhail ... more >>
    J. Januzzi, MD
  • Multiple Sclerosis — Improving the Management of Walking Impairment and Foot Drop in MS – Webcast
  • Almost two-thirds of MS patients report significant difficulty in walking. Yet, approximately 40% of patients with MS rarely or never discuss this problem with their physicians. As a result of this gap in communication, many MS patients do not experience the benefits of available pharmacologic and ... more >>
    A. Goodman, MD
  • Multiple Sclerosis — How Can We Better Manage MS Patients Today? – Webcast
  • As in the case of other chronic diseases for which treatment slows disease progression but does not provide a cure, maintaining treatment adherence over the long term is a challenge for patients with MS and their physicians. Determining treatment with both clinical outcomes and adherence in mind is ... more >>
    D. Goodin, MD
  • Multiple Sclerosis — Multiple Sclerosis Resource Network - Professional Social Network and Resource for Clinicians – Web Forum
  • The MS Resource Network serves as home to an interactive MS regional community that allows you to communicate with your local peers. Use the Members and Forum links, email function, or join a Group to connect with other clinicians and participate in MS-related discussions. The more you participate and ... more >>
  • AMD — Practice Management Update: 2007 and Beyond—Changes in AMD Management – Audio with Slides
  • This free CME/CE webcast for physicians, nurses, and practice managers presents updated information about current and emerging therapies for age-related macular degeneration (AMD), including agents that target vascular endothelial growth factor. Changes in Medicare reimbursement guidelines for 2007 and beyond ... more >>
  • Targeted Therapy — Practice Management Update: 2007 and Beyond—Changes in AMD Management – Audio with Slides
  • This free CME/CE webcast for physicians, nurses, and practice managers presents updated information about current and emerging therapies for age-related macular degeneration (AMD), including agents that target vascular endothelial growth factor. Changes in Medicare reimbursement guidelines for 2007 and beyond ... more >>
  • Multiple Sclerosis — Managing a Relapsing MS Patient With Active Disease – Case Study
  • Some patients with relapsing multiple sclerosis (MS) may have very active disease with multiple clinical and radiologic relapses despite compliance with their disease-modifying therapy. This case demonstrates the real-life clinical scenario of a male with relapsing MS who suffers multiple relapses on his ... more >>
    S. Chahin, MD, MSCE
  • Heart Failure — Managing a Heart Failure Patient With Cardiovascular Disease – Case Study
  • This case demonstrates the real-life clinical scenario of a patient with diabetes and hypertension, illustrating the work-up and diagnosis of her cardiovascular disease and heart failure. The case also highlights the guideline-recommended strategies for the treatment and subsequent optimization of medical ... more >>
    E. Hsich, MD
  • Heart Failure — Managing a Patient With Cardiovascular Disease and Severe Renal Impairment – Case Study
  • This case demonstrates the real-life clinical scenario of a patient with symptomatic heart failure and a reduced ejection fraction and renal impairment, and discusses guideline-directed medical therapy for such patients. Patients with renal impairment are eligible for treatment with most of the Class I ... more >>
    E. Hsich, MD
  • Heart Failure — Managing a Patient With a Rapid Heart Beat, Symptomatic HF, and Intolerance to Beta Blockers – Case Study
  • This case demonstrates the real-life clinical scenario of a patient with symptomatic heart failure and a reduced ejection fraction with a rapid heart rate. Guideline-directed medical therapy includes use of beta blockers, but this patient was intolerant to all but a modest dose of these agents. The evidence ... more >>
    J. Udelson, MD
  • Heart Failure — Managing a Hypertensive Black Patient With a Reduced Ejection Fraction – Case Study
  • This case demonstrates the real-life clinical scenario of a black patient with hypertension and heart failure with a reduced ejection fraction, highlighting the guideline-recommended strategies for initial treatment and subsequent optimization in black patients with heart failure.
    J. Udelson, MD
  • COPD — Case Study: Managing a Patient With Mild, Worsening COPD, Including Proper Use of Inhaler – Case Study
  • This case study in the Pulmonology Mastery in COPD program follows a 50-year-old smoker diagnosed with mild chronic obstructive pulmonary disease (COPD) who is now experiencing increasing shortness of breath. She has not been using her short-acting bronchodilator inhaler correctly, and it has been ... more >>
    B. Make, MD
  • Diabetes — Management of a Pediatric Type 1 Diabetes Mellitus Patient – Case Study
  • This case illustrates the real-life clinical scenario of a young patient with type 1 diabetes mellitus (T1DM). It highlights important considerations in the diagnosis of T1DM, reviews treatment recommendations, and illustrates important screening recommendations.
    L. Jacobsen, MD
    D. Schatz, MD
  • COPD — Case Study: Managing Mild to Moderate COPD in a Patient With Exacerbations – Case Study
  • Acute exacerbations of chronic obstructive pulmonary disease (COPD) can occur even in patients with mild to moderate obstruction to airflow. For this reason, it is imperative to ensure these patients receive effective treatment as early as possible in the disease. This case illustrates the real-life scenario ... more >>
    B. Make, MD
  • Stroke Prevention — Patient with New Onset Atrial Fibrillation – Case Study
  • Atrial fibrillation substantially increases the risk of stroke; thus, stroke prevention is a priority in all patients with atrial fibrillation. However, not all patients may need anticoagulation therapy. In this case of a patient with only one symptomatic episode of atrial fibrillation spontaneously ... more >>
    C. Yancy, MD, MSc
  • Stroke Prevention — Heart Failure Patient with Atrial Fibrillation, Not Previously Treated – Case Study
  • Since patients with atrial fibrillation face a significant increase in the risk of stroke, determining stroke prophylaxis and identifying patients requiring therapy is a high priority. In this case study, Dr. Yancy discusses the risk factors for stroke in patients with heart failure and atrial fibrillation, ... more >>
    C. Yancy, MD, MSc